Fero M L, Randel E, Gurley K E, Roberts J M, Kemp C J
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.
Nature. 1998 Nov 12;396(6707):177-80. doi: 10.1038/24179.
p27Kip is a candidate human tumour-suppressor protein, because it is able to inhibit cyclin-dependent kinases and block cell proliferation. Abnormally low levels of the p27 protein are frequently found in human carcinomas, and these low levels correlate directly with both histological aggressiveness and patient mortality. However, it has not been possible to establish a causal link between p27 and tumour suppression, because only rare instances of homozygous inactivating mutations of the p27 gene have been found in human tumours. Thus, p27Kip1 does not fulfil Knudson's 'two-mutation' criterion for a tumour-suppressor gene. Here we show that both p27 nullizygous and p27 heterozygous mice are predisposed to tumours in multiple tissues when challenged with gamma-irradiation or a chemical carcinogen. Therefore p27 is a multiple-tissue tumour suppressor in mice. Molecular analyses of tumours in p27 heterozygous mice show that the remaining wild-type allele is neither mutated nor silenced. Hence, p27 is haplo-insufficient for tumour suppression. The assumption that null mutations in tumour-suppressor genes are recessive excludes those genes that exhibit haplo-insufficiency.
p27Kip是一种潜在的人类肿瘤抑制蛋白,因为它能够抑制细胞周期蛋白依赖性激酶并阻断细胞增殖。在人类癌症中经常发现p27蛋白水平异常低,而且这些低水平与组织学侵袭性和患者死亡率直接相关。然而,尚未能够在p27与肿瘤抑制之间建立因果联系,因为在人类肿瘤中仅发现了罕见的p27基因纯合失活突变实例。因此,p27Kip1不符合Knudson关于肿瘤抑制基因的“双突变”标准。我们在此表明,当受到γ射线照射或化学致癌物攻击时,p27基因纯合缺失和杂合的小鼠在多个组织中都易患肿瘤。因此,p27在小鼠中是一种多组织肿瘤抑制因子。对p27杂合小鼠肿瘤的分子分析表明,剩余的野生型等位基因既未发生突变也未沉默。因此,p27对于肿瘤抑制是单倍体不足的。肿瘤抑制基因中的无效突变是隐性的这一假设排除了那些表现出单倍体不足的基因。